Obesity Linked to 229 Diseases, Experts Warn in Pakistan

Obesity is linked to as plenty of as 229 diseases and may shorten life by five to 11 years, senior endocrinologists and medical specialists have cautioned, calling for early lifestyle changes and medically supervised treatment.

Key points

• Organisers remarked free guidance from medical experts was available at health-fitness.pk or by calling (021) 111-455-455.
• More than 1, 100 doctors from Sindh and other parts of the country attended the Metabolic Health Forum at Getz Pharma's Astola facility.
• International Diabetes Federation figures show that 34.5 million Pakistani adults have diabetes, with prevalence reaching 31.4 percent.
• He remarked Getz Pharma exports medicines to concerning 45 countries and is expanding into Eastern Europe and South America while additionally generating local treatment data.
• Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.

In practice, the experts remarked Pakistan now has access to some of the world's most affordable advanced medicines and therapies for obesity, diabetes and related complications.

More than 1, 100 doctors from Sindh and other parts of the country attended the Metabolic Health Forum at Getz Pharma's Astola facility. They described obesity as a major driver of diabetes, heart disease, kidney failure, disability and premature death. Nationwide Hepatitis C Screening Drive Delayed.

Endocrinologist Dr Abbas Raza remarked obesity causes or contributes to 229 diseases. He remarked data demonstrated knee osteoarthritis in 52 percent of obese individuals, hypertension in 51 percent, sleep apnoea in 40 percent, fatty liver disease in 29 percent, heart attacks and diabetes in 21 percent each, and major depression in 19 percent.

He remarked one in four Pakistanis, or 25 percent of the population, is living with obesity, including women and children. He remarked obesity is not an problem of appearance or willpower.

Dr Raza blamed urbanisation, sedentary routines, sugary drinks, energy-dense foods and limited physical activity for the rising burden.

He remarked more than 75 percent of residents with excess weight do not consider themselves overweight or obese and therefore fail to change their lifestyles or seek support before complications develop.

Dr Raza remarked Pakistanis are fortunate to have early access to advanced medicines at affordable costs. He remarked semaglutide can assist suitable patients alongside healthier diets, exercise and long-term follow-up. Study Suggests the Human Brain Evolved as Two Separate Organs.

International Diabetes Federation figures show that 34.5 million Pakistani adults have diabetes, with prevalence reaching 31.4 percent. Dr Raza remarked obesity is often addressed only after complications emerge.

Getz Pharma Deputy Managing Director Zeeshan Ahmed remarked the business has invested heavily in manufacturing, quality systems and research to provide safe and effective medicines.

Prof A.H. Amir remarked GLP-1 medicines act like a natural signal that helps control appetite and blood sugar. He remarked they could prove cost-effective by preventing hospital admissions, disability and expensive heart and kidney complications.

Prof Saeed A. Mahar remarked body mass index is useful but should not be the only factor in treatment decisions. He remarked doctors should additionally consider waist size, illnesses and previous attempts involving diet and exercise.

Dr Faisal Masood Qureshi remarked Pakistan is producing affordable weight-control medicines that meet international quality standards. He stressed uninterrupted supply and safeguards against counterfeit products and unsupervised employ.

Evidence presented at the forum indicated that semaglutide may offer benefits beyond weight and blood sugar control. While the FLOW study noted a 24 percent reduction in serious kidney outcomes among relevant high-risk patients, the SELECT study discovered a 20 percent reduction in cardiovascular death, heart attack and stroke. CM Punjab Announces Cancer Hospital in Every Division of Province.

Experts remarked a major trial identified that patients receiving semaglutide lost almost 15 percent of their body weight. An Endocrine Practice review additionally noted feasible heart, kidney, liver and quality-of-life benefits.

Meanwhile, the panel discussion included Dr Saima Askari, Dr M A Ebrahim, Prof Karim Kammeruddin, Dr Jawaid Sami, Dr Najam Mahmudi, Dr Saif-ul-Haq, Dr Shahid Akhtar, Dr Shakeel Haider and Dr Ali Asghar.

Meanwhile, the experts cautioned that semaglutide is not a miracle injection and should not be employed for unsupervised cosmetic weight loss. They pressed healthier lifestyles, trained prescribers, affordable treatment, and protection against counterfeit medicines. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover.

Add as a preferredSource on Google Follow on Google News Join WhatsApp.

In short, obesity Linked to 229 Diseases, Experts Warn in Pakistan is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.